Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis

NCT00153062 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00153062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis
Lead sponsor
Boehringer Ingelheim
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
Not reported
Enrollment
20,332 (actual)
Sites
667

Conditions

As the registry lists them; a condition with its own page is linked.

stroke